Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ocular Therapeutix is a leading US-based biopharmaceutical company specializing in innovative ophthalmology. Leveraging its proprietary hydrogel platform, the company develops sustainable therapies focused on the treatment of serious diseases affecting the ocular surface.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ocular Therapeutix is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Ocular Therapeutix last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at -0.35 USD.
Ocular Therapeutix has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.